GEHC in the 13F filings
Ge Healthcare Technologies I · CUSIP 36266G107
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 36
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 10 listed it in both
- Shares listed
- 95,052,919
- combined, among listed positions
- Reported value
- $6.8bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 19 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -9,806,913.
Managers listing GEHC in Q1 2026
36 of 36 holders
Largest increases and reductions, by shares
Increases
- Citadel Advisors LLCexisting position · 1,293,268 shares now+917,266
- Renaissance Technologies LLCnew position · 254,100 shares now+254,100
- Millennium Management LLCexisting position · 170,622 shares now+165,738
- Marshall Wace LLPexisting position · 172,005 shares now+133,814
- Dodge & Coxexisting position · 31,312,064 shares now+100,835
Reductions
- Capital Research Global Investorsexisting position · 21,108,753 shares now-4,253,599
- T. Rowe Price Associates Incexisting position · 654,401 shares now-1,114,975
- D. E. Shaw & Co.existing position · 470,374 shares now-837,294
- Fidelity (FMR LLC)existing position · 2,775,113 shares now-576,684
- AQR Capital Management LLCexisting position · 145,277 shares now-334,813
New positions and exits
New (6)
Exited (3)
- Holocene Advisors LPwas $184m
- D1 Capital Partners LPwas $145m
- Soros Fund Management LLCwas $3.9m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2022 | 1 | $371m | n.a. | n.a. |
| Q1 2023 | 13 | $8.0bn | n.a. | n.a. |
| Q2 2023 | 21 | $8.7bn | n.a. | n.a. |
| Q3 2023 | 14 | $6.6bn | n.a. | n.a. |
| Q4 2023 | 13 | $7.3bn | 7 | 8 |
| Q1 2024 | 17 | $9.7bn | 10 | 5 |
| Q2 2024 | 17 | $8.0bn | 9 | 5 |
| Q3 2024 | 20 | $10.7bn | 9 | 11 |
| Q4 2024 | 18 | $8.8bn | 10 | 6 |
| Q1 2025 | 18 | $8.4bn | 9 | 11 |
| Q2 2025 | 22 | $7.2bn | 15 | 6 |
| Q3 2025 | 14 | $6.3bn | 6 | 9 |
| Q4 2025 | 13 | $8.1bn | 17 | 22 |
| Q1 2026 | 11 | $6.3bn | 19 | 18 |
| Q2 2026 | 9 | $4.9bn | 24 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GEHC and LLY →GEHC and JNJ →GEHC and VRTX →Choose a stock to compare with GEHC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GEHC, latest filings →Back to the 13F Explorer →